INTEGRA LIFESCIENCES HOLDINGS CORP Deferred Income Tax Assets, Net
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Deferred Income Tax Assets, Net of $70.44 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-07-29
- 2026-06-30: Deferred Income Tax Assets, Net $70.44M.
- 2026-03-31: Deferred Income Tax Assets, Net $68.08M.
- 2025-12-31: Deferred Income Tax Assets, Net $69.85M.
- 2025-09-30: Deferred Income Tax Assets, Net $109.73M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $70.44M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $68.08M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $69.85M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $109.73M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $102.94M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $38.01M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $34.92M 10-K · filed 2026-02-26 |
| 2024-09-30 | $48.94M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $45.76M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $34.17M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $46.08M 10-K · filed 2025-02-25 |
| 2023-09-30 | $55.59M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $56.05M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $44.68M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $45.99M 10-K · filed 2024-02-28 |
| 2022-09-30 | $51.77M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $46.98M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $54.68M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $56.95M 10-K · filed 2023-02-22 |
| 2021-09-30 | $91.80M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $80.09M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $74.63M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $73.69M 10-K · filed 2022-02-24 |
| 2020-09-30 | $8.15M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $7.53M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.33M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $12.62M 10-K · filed 2021-02-23 |
| 2019-09-30 | $27.00M 10-Q · filed 2019-10-25 |
| 2019-06-30 | $22.44M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $16.40M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $6.80M 10-K · filed 2020-02-21 |
| 2018-09-30 | $7.23M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $7.68M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $6.46M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $6.25M 10-K · filed 2019-02-26 |
| 2017-09-30 | $6.35M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $6.21M 10-Q · filed 2017-07-26 |
| 2016-12-31 | $6.93M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |